Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up

Journal of Substance Abuse Treatment

Volumn 24, Issue 4, 2003, Pages 313-321

  Gossop, Michael ^a   Stewart, Duncan ^a   Browne, Nadine ^a   Marsden, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

General practice; Methadone; Treatment outcomes

Indexed keywords

BENZODIAZEPINE; ILLICIT DRUG; METHADONE;

ADULT; ARTICLE; CLINICAL PRACTICE; CRIME; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL HEALTH; METHADONE TREATMENT; OPIATE ADDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0037674449     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(03)00040-0     Document Type: Article

References (61)

1. Anglin M.D., Hser Y.I. Treatment of drug abuse. Torey M., Wilson J.Q. Drugs and Crime. 1990;393-460 University of Chicago, Chicago.
2. Drugs: Dilemmas and choices. 2000;Gaskell, London.
3. Barrau K., Thirion X., Micallef J., Chuniaud-Louche C., Bellemin B., San Marco J. Comparison of methadone and high dosage buprenorphine users in French care centres. Addiction. 96:2001;1433-1441.
4. Ball J., Ross A. The effectiveness of methadone maintenance treatment. 1991;Springer, New York.
5. Bell G., Cohen J., Cremona A. How willing are general practitioners to manage narcotic misuse? Health Trends. 22:1990;56-57.
6. Byrne A., Wodak A. Census of patients receiving methadone treatment in a general practice. Addiction Research. 3:1996;341-349.
7. Byrne A. Nine-year follow-up of 86 consecutive patients treated with methadone in general practice, Sydney, Australia. Drug and Alcohol Review. 19:2000;153-158.
8. Cohen J., Schamroth A., Nazareth I., Johnson M., Graham S., Thomson D. Problem drug use in a central London general practice. British Medical Journal. 304:1992;1158-1160.
9. Cooper J.R. Including narcotic addiction treatment in an office-based practice. Journal of the American Medical Association. 273:1995;1619-1620.
10. Darke S., Ward J., Zadar D., Swift G. A scale for estimating the health status of opioid users. British Journal of Addiction. 86:1991;1317-1322.
11. D'Aunno T., Vaughn T.E. Variations in methadone treatment practices. American Medical Association. 267:1992;253-258.
12. DeLeon G. Alcohol: the hidden drug among substance abusers. British Journal of Addiction. 84:1989;837-840.
13. Statistics from the regional drug misuse databases on drug misusers in treatment in England, 2000/1. 2001;Department of Health.
14. Scottish Office, Department of Health, Welsh Office, Department of Health and Social Services, Northern Ireland. Drug misuse and dependence: Guidelines on clinical management. 1999;The Stationery Office.
15. Derogatis L.R. The Brief Symptom Inventory administration, scoring and procedures. 1993;National Computer Systems, Minneapolis, MN.
16. Durand M.A. General practice involvement in the management of alcohol misuse: dynamics and resistances. Drug and Alcohol Dependence. 35:1994;181-189.
17. Etheridge R.M., Craddock S.G., Dunteman G.H., Hubbard R.L. Treatment services in two national studies of community-based drug abuse treatment programs. Journal of Substance Abuse. 7:1995;9-26.
18. Etheridge R.M., Craddock S.G., Hubbard R.L., Rounds-Bryant J.L. The relationship of counseling and self-help participation to patient outcomes in DATOS. Drug and Alcohol Dependence. 57:1999;99-112.
19. Farrell M., Ward J., Mattick R., Hall W., Stimson G.V., des Jarlais D., Gossop M., Strang J. Methadone maintenance treatment in opiate dependence. British Medical Journal. 309:1994;997-1001.
20. Fiellin D.A., O'Connor P.G., Chawarski M., Pakes J.P., Pantalon M.V., Schottenfeld R.S. Methadone maintenance in primary care: a randomized controlled trial. Journal of the American Medical Association. 286:2001;1724-1731.
21. Fiorentine R., Anglin M.D. More is better: counseling participation and the effectiveness of outpatient drug treatment. Journal of Substance Abuse Treatment. 13:1996;341-348.
22. Fletcher B.W., Tims F.M., Brown B.S. Drug Abuse Treatment Outcome Study (DATOS): Treatment evaluation research in the United States. Psychology of Addictive Behaviors. 11:1997;216-229.
23. Glanz A., Taylor C. Findings of a national survey of the role of general practitioners in the treatment of opiate misuse: extent of contact with opiate misusers. British Medical Journal. 293:1986;427-430.
24. Glanz A. The fall and rise of the general practitioner. Strang J., Gossop M. Heroin addiction and drug policy: The British system. 1994;150-166 Oxford University Press, Oxford.
25. Gossop M., Best D., Marsden J., Strang J. Test-retest reliability of the Severity of Dependence Scale. Addiction. 92:1997;353.
26. Gossop M., Grant M. A six country survey of the content and structure of heroin treatment programmes using methadone. British Journal of Addiction. 86:1991;1151-1160.
27. Gossop M., Marsden J., Stewart D., Edwards C., Lehmann P., Wilson A., Segar G. NTORS The National Treatment Outcome Research Study: Summary of the project, the clients, and preliminary findings: First bulletin. 1996;Department of Health, London.
28. Gossop M., Marsden J., Stewart D., Edwards C., Lehmann P., Wilson A., Segar G. The National Treatment Outcome Research Study in the United Kingdom: six month follow-up outcomes. Psychology of Addictive Behaviors. 11:1997;324-337.
29. Gossop M., Marsden J., Stewart D., Lehmann P., Edwards C., Wilson A., Segar G. Substance use, health and social problems of clients at 54 drug treatment agencies: intake data from the National Treatment Outcome Research Study (NTORS). British Journal of Psychiatry. 173:1998;166-171.
30. Gossop M., Marsden J., Stewart D., Rolfe A. Patterns of drinking and drinking outcomes among drug misusers: one year follow-up results. Journal of Substance Abuse Treatment. 19:2000;45-50.
31. Gossop M., Marsden J., Stewart D., Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence. 62:2001;255-264.
32. Gossop M., Marsden J., Stewart D., Treacy S. Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study. AIDS Care. 14:2002;77-93.
33. Gossop M., Marsden J., Stewart D., Lehmann P., Strang J. Methadone treatment practices and outcome among opiate addicts treated in drug clinics and general practice settings: results from the National Treatment Outcome Research Study - NTORS. British Journal of General Practice. 49:1999;31-34.
34. Gossop M., Marsden J., Stewart D. Dual dependence: assessment of dependence upon alcohol and illicit drugs, and the relationship of alcohol dependence among drug misusers patterns of drinking, illicit drug use, and health problems. Addiction. 97:2002;169-178.
35. Groves P., Heuston J., Durand M.A., Albery I., Gossop M., Strang J. The identification and management of substance misuse problems by general practitioners. Journal of Mental Health. 5:1996;183-193.
36. Gruer L., Wilson P., Scott R., Elliot L., Macleod J., Harden K., Forrester E., Hinshelwood S., McNulty H., Silk P. General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. British Medical Journal. 314:1997;1730-1735.
37. Hser Y.I., Polinsky M.L., Maglione M., Anglin M.D. Matching clients' needs with drug treatment services. Journal of Substance Abuse Treatment. 16:1999;299-305.
38. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M. Drug abuse treatment: A national study of effectiveness. 1989;University of North Carolina Press, Chapel Hill.
39. Hutchinson S.J., Taylor A., Gruer L., Barr C., Mills C., Elliot L., Goldberg D.J., Scott R., Gilchrist G. One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme. Addiction. 95:2000;1055-1068.
40. King V.L., Stoller K.B., Hayes M., Umbricht A., Currens M., Kidorf M.S., Carter J.A., Schwartz R., Brooner R.K. A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence. 65:2002;132-148.
41. Lehman W.E., Barrett M.E., Simpson D.D. Alcohol use by heroin addicts 12 years after drug abuse treatment. Journal of Studies on Alcohol. 51:1990;233-244.
42. Lewis D., Bellis M. General practice or drug clinic for methadone maintenance? A controlled comparison of treatment outcomes. International Journal of Drug Policy. 12:2001;81-89.
43. McKeganey N. Shadowland: General practitioners and the treatment of opiate-abusing patients. British Journal of Addiction. 83:1988;373-386.
44. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., O'Brien C.P. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association. 269:1993;1953-1959.
45. McLellan A.T., Grissom G.R., Zanis D., Randall M., Brill P., O'Brien C.P. Problem-service 'matching' in addiction treatment. A prospective study in 4 programs. Archives of General Psychiatry. 54:1997;730-735.
46. Peters A.D., Reid M.M. Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian. Drug and Alcohol Dependence. 50:1998;47-55.
47. Roche A.M., Guray C., Saunders J.B. General practitioners' experiences of patients with drug and alcohol problems. British Journal of Addiction. 86:1991;263-275.
48. Simpson D. Effectiveness of drug-abuse treatment: a review of research from field settings. Egertson J.A., Fox D.M., Leshner A.I. Treating drug abusers effectively. 1997;41-73 Blackwell, Oxford, UK.
49. Simpson D.D., Joe G.W., Fletcher B.W., Hubbard R.L., Anglin M.D. A national evaluation of treatment outcomes for cocaine dependence. Archives of General Psychiatry. 56:1999;507-514.
50. Simpson D.D., Lloyd M.R. Alcohol use following treatment for drug addiction. A four-year follow-up. Journal of Studies on Alcohol. 42:1981;323-335.
51. Simpson D.D., Sells S.B. Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol & Substance Abuse. 2:1982;7-29.
52. Simpson D.D., Sells S.B. Opioid addiction and treatment: a 12 year follow-up. 1990;Kreiger, Malabar, FL.
53. Sorensen J.L., Copeland A.L. Drug abuse treatment as an HIV prevention strategy: A review. Drug & Alcohol Dependence. 59:2000;17-31.
54. Sorensen J.L. Methadone treatment for opiate addiction. British Medical Journal. 313:1996;245-246.
55. Strang J., Griffiths P., Abbey J., Gossop M. Survey of use of injected benzodiazepines among drug users in Britain. British Medical Journal. 308:1994;1082.
56. Strang J., Sheridan J. National and regional characteristics of methadone prescribing in England and Wales: local analyses of data from the 1995 national survey of community pharmacies. Journal of Substance Misuse. 3:1998;240-246.
57. Strang J., Sheridan J., Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacists in England and Wales. British Medical Journal. 13:1996;270-272.
58. Ward J., Mattick R.P., Hall W. Key issues in methadone maintenance treatment. 1992;New South Wales University Press, Sydney.
59. Ward J., Mattick R.P., Hall W. Methadone maintenance treatment and other opioid replacement therapies. 1998;Harwood Academic Publishers, Amsterdam.
60. Weinrich M., Stuart M. Provision of methadone treatment in primary care medical practices: Review of the Scottish experience and implications for US policy. Journal of the American Medical Association. 283:2000;1343-1348.
61. Wilson P., Watson R., Ralston G.E. Methadone maintenance in general practice. British Medical Journal. 309:1994;641-644.